Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China · Delayed Price · Currency is CNY 10.26
+0.23 (2.29%)
Feb 4, 2026, 1:15 PM CST
SHE:300016 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 33.43 | 13.65 | -71.76 | 11.28 | 125.51 | 174.7 |
Depreciation & Amortization | 94.12 | 94.12 | 84.46 | 77.65 | 62.83 | 42.7 |
Other Amortization | 5.93 | 5.93 | 3.89 | 2.86 | 1.08 | 1.2 |
Loss (Gain) From Sale of Assets | -0.12 | -0.12 | -0.89 | -0.1 | -0.13 | - |
Asset Writedown & Restructuring Costs | 1.14 | 1.14 | 33.06 | 19.77 | 0.76 | 4.34 |
Loss (Gain) From Sale of Investments | 4.59 | 4.59 | 7.96 | -22.99 | -28.5 | -25.07 |
Provision & Write-off of Bad Debts | -0.94 | -0.94 | 3.64 | -0.88 | -1.45 | 0.31 |
Other Operating Activities | 26.71 | 54.83 | 58.01 | 38.78 | 28.87 | -11.79 |
Change in Accounts Receivable | 38.55 | 38.55 | -52.91 | 33.88 | 60.4 | -13.75 |
Change in Inventory | -86.91 | -86.91 | 24.71 | -27.03 | -131.04 | 13.36 |
Change in Accounts Payable | 35.81 | 35.81 | -9.58 | 10.13 | 36.48 | -3.06 |
Change in Other Net Operating Assets | 3.46 | 3.46 | -4.12 | -6.94 | -40.09 | -4.27 |
Operating Cash Flow | 154.68 | 163.02 | 58.46 | 127.81 | 108.73 | 176 |
Operating Cash Flow Growth | 14.75% | 178.86% | -54.26% | 17.55% | -38.22% | 12.24% |
Capital Expenditures | -195.35 | -101.39 | -144.61 | -102.78 | -147.76 | -172.1 |
Sale of Property, Plant & Equipment | -2.93 | 1.67 | 21.96 | 0.01 | 0.17 | 0.35 |
Cash Acquisitions | - | -148.61 | - | - | - | 6.2 |
Investment in Securities | -341.56 | -345.62 | 4.29 | 1.35 | -24.14 | 6.4 |
Other Investing Activities | 444.6 | 13.18 | 4.04 | 10.21 | 27.68 | 7.94 |
Investing Cash Flow | -95.25 | -580.76 | -114.32 | -91.21 | -144.04 | -151.21 |
Short-Term Debt Issued | - | - | - | - | - | 7.6 |
Long-Term Debt Issued | - | 215.85 | 323.22 | 101 | 64.71 | 873.78 |
Total Debt Issued | 377.18 | 215.85 | 323.22 | 101 | 64.71 | 881.38 |
Short-Term Debt Repaid | - | - | - | - | - | -7.6 |
Long-Term Debt Repaid | - | -292.14 | -219.23 | -82.03 | -219.69 | -105.5 |
Total Debt Repaid | -321.88 | -292.14 | -219.23 | -82.03 | -219.69 | -113.1 |
Net Debt Issued (Repaid) | 55.3 | -76.29 | 103.99 | 18.97 | -154.98 | 768.28 |
Repurchase of Common Stock | - | - | -0.1 | -3.4 | -8.38 | -0.9 |
Common Dividends Paid | -46.04 | -20.9 | -50.72 | -52.54 | -44.9 | -41.52 |
Other Financing Activities | -6.35 | - | -0 | -123.32 | 108.3 | -3.26 |
Financing Cash Flow | 2.91 | -97.19 | 53.17 | -160.29 | -99.95 | 722.59 |
Foreign Exchange Rate Adjustments | -1.17 | 0.26 | -2.52 | 0.29 | -0.19 | - |
Net Cash Flow | 61.17 | -514.67 | -5.21 | -123.4 | -135.45 | 747.39 |
Free Cash Flow | -40.68 | 61.63 | -86.15 | 25.03 | -39.03 | 3.9 |
Free Cash Flow Growth | - | - | - | - | - | -96.80% |
Free Cash Flow Margin | -3.61% | 6.27% | -9.67% | 3.27% | -4.54% | 0.47% |
Free Cash Flow Per Share | -0.09 | 0.14 | -0.18 | 0.04 | -0.08 | 0.01 |
Cash Income Tax Paid | 72.01 | 64.22 | 45.17 | 64.27 | 63 | 94.14 |
Levered Free Cash Flow | -171.49 | -24.13 | -156.23 | -58.31 | -112.52 | -5.12 |
Unlevered Free Cash Flow | -139.51 | 12.12 | -123.02 | -28.53 | -84.91 | -2.09 |
Change in Working Capital | -10.18 | -10.18 | -59.91 | 1.44 | -80.24 | -10.39 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.